Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis.

about

Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture

P2860

Q57807139-215B276F-55F9-4BFF-9887-30D4C71354ED

P2860

Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis.

Item

http://www.wikidata.org/entity/Q55442446

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Newer Oral Anticoagulants in t ...... ts with and without Cirrhosis.

@en

Newer Oral Anticoagulants in t ...... ts with and without Cirrhosis.

@nl

type

Item

label

Newer Oral Anticoagulants in t ...... ts with and without Cirrhosis.

@en

Newer Oral Anticoagulants in t ...... ts with and without Cirrhosis.

@nl

prefLabel

Newer Oral Anticoagulants in t ...... ts with and without Cirrhosis.

@en

Newer Oral Anticoagulants in t ...... ts with and without Cirrhosis.

@nl

P1476

Newer Oral Anticoagulants in t ...... ts with and without Cirrhosis.

@en

P2093

M Krafft

http://www.w3.org/2001/XMLSchema#string

N A Shah

http://www.w3.org/2001/XMLSchema#string

P2860

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

Dabigatran versus warfarin in patients with atrial fibrillation

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.

Efficacy and Safety of Direct-Acting Oral Anticoagulants Use in Acute Portal Vein Thrombosis Unrelated to Cirrhosis.

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis.

Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.

Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation

P304

8432781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/8432781

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Justin T Kupec

Gorman Joel Reynolds

P Priyanka

P577

2018-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29973997

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

anticoagulation

P932

6008786

http://www.w3.org/2001/XMLSchema#string

Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis.

about

P2860

P2860

Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932